{"product_id":"global-ambulatory-polysomnography-psg-systems-market-size-study-forecast-by-product-up-to-12-channel-psg-systems-up-to-24-channel-psg-systems-up-to-32-channel-psg-systems-and-above-32-channel-psg-systems-application-obstructive-sleep-apnea-n","title":"Global Ambulatory Polysomnography (Psg) Systems  Market Size study \u0026 Forecast, by Product (Up to 12 Channel PSG Systems, Up to 24 Channel PSG Systems, Up to 32 Channel PSG Systems, and Above 32 Channel PSG Systems), Application (Obstructive Sleep Apnea, N","description":"\u003cp\u003eGlobal Ambulatory Polysomnography (Psg) Systems  Market Size study \u0026amp; Forecast, by Product (Up to 12 Channel PSG Systems, Up to 24 Channel PSG Systems, Up to 32 Channel PSG Systems, and Above 32 Channel PSG Systems), Application (Obstructive Sleep Apnea, Narcolepsy, Chronic Insomnia, and Others), End-user (Hospitals, Sleep Laboratories, and Home Care Settings),and Regional Analysis, 2023-2030\u003cbr\u003e\nGlobal Ambulatory Polysomnography (Psg) Systems Market is valued approximately at USD 346.6 million in 2022 and is anticipated to grow with a growth rate of more than 1.5% over the forecast period 2023-2030. The ambulatory polysomnography (PSG) system is designed to provide portable diagnostic devices and associated services that allow for the monitoring and analysis of sleep patterns and physiological parameters in patients outside of a conventional sleep laboratory. The ambulatory polysomnography psg system market is driven by factors such as increasing demand for portable and home PSG devices and increasing cases of sleeping disorder. These systems help identify and analyse the sleeping pattern of patient out the conventional sleep laboratory According to sleep foundation estimates, 50 million to 70 million people in the U.S. have ongoing sleep disorders along with that 76% U.S adults facing disorder and along with that according to statista the sleeping disorder cases registered in Spain in year 2021 was 4,041, 527.Thus rising in sleeping disorder cases fueling the growth of the market. In addition the use of AI in PSG system and large undiagnosed population may create the lucrative opportunities for the market. However, the lack of awareness about sleeping disorder may hinder the growth of the market.\u003c\/p\u003e\n\n\u003cp\u003eThe key regions considered for the Global Ambulatory Polysomnography (Psg) Systems Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East \u0026amp; Africa. North America dominated the market in 2022 owing to increasing cases of sleeping disorder.And Europe is considered as the fastest growing region during the forecasted period due to the presence of multiple manufacturers \u0026amp; high level of awareness about sleeping disorder and rising healthcare expenditure.\u003c\/p\u003e\n\n\u003cp\u003eMajor market player included in this report are:\u003cbr\u003e\nKoninklijke Philips N.V\u003cbr\u003e\nNatus Medical Incorporated\u003cbr\u003e\nNihon kohden corporation\u003cbr\u003e\nNoxMedical\u003cbr\u003e\nLowenstein medical technology Gmbh +co..KG\u003cbr\u003e\nNeurosoft\u003cbr\u003e\nCadwell industries Inc.\u003cbr\u003e\nSomnomedics Gmbh\u003cbr\u003e\nCompumedics Ltd.\u003cbr\u003e\nOnera technologies B.V\u003c\/p\u003e\n\n\u003cp\u003eRecent Developments in the Market:\u003cbr\u003e\nIn august 2020, Somnomedics Gmbh recived FDA approval for use of Somnoscreen HD,Somnoscreen plus ,and Somnoscreen eco in the pediatric population as younger as 2 years old.\u003cbr\u003e\nIn july 2019 ,natus medical incorporated oprnd a new distribution center in Galway, Irland it ia a 22000sq foot facility and expanded thr existing Natus facility in Gort over 66000sq foot.\u003c\/p\u003e\n\n\u003cp\u003eGlobal Ambulatory Polysomnography (Psg) Systems Market Report Scope:\u003cbr\u003e\nHistorical Data – 2020 - 2021\u003cbr\u003e\nBase Year for Estimation – 2022\u003cbr\u003e\nForecast period - 2023-2030\u003cbr\u003e\nReport Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends\u003cbr\u003e\nSegments Covered - Product, Application, End User, Region\u003cbr\u003e\nRegional Scope - North America; Europe; Asia Pacific; Latin America; Middle East \u0026amp; Africa\u003c\/p\u003e\n\n\u003cp\u003eThe objective of the study is to define market sizes of different segments \u0026amp; countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.\u003c\/p\u003e\n\n\u003cp\u003eThe report also caters detailed information about the crucial aspects such as driving factors \u0026amp; challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:\u003c\/p\u003e\n\n\u003cp\u003eBy Product:\u003cbr\u003e\nUp to 12 Channel PSG Systems\u003cbr\u003e\nUp to 24 Channel PSG Systems\u003cbr\u003e\nUp to 32 Channel PSG Systems\u003cbr\u003e\nAbove 32 Channel PSG Systems\u003c\/p\u003e\n\n\u003cp\u003eBy Application:\u003cbr\u003e\nObstructive Sleep Apnea\u003cbr\u003e\nNarcolepsy\u003cbr\u003e\nChronic Insomnia\u003cbr\u003e\nOthers\u003cbr\u003e\nBy End User:\u003cbr\u003e\nHospitals\u003cbr\u003e\nSleep Laboratories\u003cbr\u003e\nHome Care Settings\u003c\/p\u003e\n\n\u003cp\u003eBy Region:\u003c\/p\u003e\n\n\u003cp\u003eNorth America\u003cbr\u003e\nU.S.\u003cbr\u003e\nCanada\u003c\/p\u003e\n\n\u003cp\u003eEurope\u003cbr\u003e\nUK\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nSpain\u003cbr\u003e\nItaly\u003cbr\u003e\nROE\u003c\/p\u003e\n\n\u003cp\u003eAsia Pacific\u003cbr\u003e\nChina\u003cbr\u003e\nIndia\u003cbr\u003e\nJapan\u003cbr\u003e\nAustralia\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nRoAPAC\u003c\/p\u003e\n\n\u003cp\u003eLatin America\u003cbr\u003e\nBrazil\u003cbr\u003e\nMexico\u003c\/p\u003e\n\n\u003cp\u003eMiddle East \u0026amp; Africa\u003cbr\u003e\nSaudi Arabia\u003cbr\u003e\nSouth Africa\u003cbr\u003e\nRest of Middle East \u0026amp; Africa\u003c\/p\u003e\n\n\u003cp\u003eCompanies Mentioned\u003cbr\u003e\nKoninklijke Philips N.V\u003cbr\u003e\nNatus Medical Incorporated\u003cbr\u003e\nNihon kohden corporation\u003cbr\u003e\nNoxMedical\u003cbr\u003e\nLowenstein medical technology Gmbh +co..KG\u003cbr\u003e\nNeurosoft\u003cbr\u003e\nCadwell industries Inc.\u003cbr\u003e\nSomnomedics Gmbh\u003cbr\u003e\nCompumedics Ltd.\u003cbr\u003e\nOnera technologies B.V\u003c\/p\u003e\n\n\u003cp\u003ePlease note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"June, 2023 \/ 200 Pages \/ MCW16241703","offer_id":47657982624050,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-ambulatory-polysomnography-psg-systems-market-size-study-forecast-by-product-up-to-12-channel-psg-systems-up-to-24-channel-psg-systems-up-to-32-channel-psg-systems-and-above-32-channel-psg-systems-application-obstructive-sleep-apnea-n","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}